CORC

浏览/检索结果: 共5条,第1-5条 帮助

已选(0)清除 条数/页:   排序方式:
Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis 期刊论文
BMC CANCER, 2019, 卷号: 19
作者:  Zhou, Min;  Sun, Xiaoying;  Roudi, Raheleh;  Dai, Ting;  Chen, Shangya
收藏  |  浏览/下载:40/0  |  提交时间:2019/12/05
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Zhou, Jian-Guo;  Zhong, Hua;  Zhang, Juan;  Jin, Su-Han;  Roudi, Raheleh
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis 期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 44
作者:  Sun, Xiaoying;  Roudi, Raheleh;  Chen, Shangya;  Fan, Bin;  Li, Hong Jin
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent 期刊论文
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, 期号: 12
作者:  Zhu, Jianwei;  Li, Rui;  Tiselius, Eva;  Roudi, Raheleh;  Teghararian, Olivia
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis 期刊论文
Medicine, 2017, 卷号: 96, 页码: e8407
作者:  Sun Xiaoying[1];  Roudi Raheleh[2];  Chen Shangya[3];  Fan Bin[4];  Li Hong Jin[5]
收藏  |  浏览/下载:4/0  |  提交时间:2019/04/26


©版权所有 ©2017 CSpace - Powered by CSpace